Multi-omics profiling of cholangiocytes reveals sex-specific chromatin state dynamics during hepatic cystogenesis in polycystic liver disease-Reference-Cited by-同舟云学术

Multi-omics profiling of cholangiocytes reveals sex-specific chromatin state dynamics during hepatic cystogenesis in polycystic liver disease

Published:2023-04 Issue:4 Volume:78 Page:754-769
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Ji Rongjie,Chen Jiayuan^ORCID,Xie Yuyang,Dou Xudan,Qing Bo,Liu Zhiheng^ORCID,Lu Yumei,Dang Lin,Zhu Xu,Sun Ying,Zheng Xiangjian,Zhang Lirong^ORCID,Guo Dong^ORCID,Chen Yupeng

Publisher

Elsevier BV

Subject

Hepatology

Reference99 articles.

1. Polycystic liver diseases: advanced insights into the molecular mechanisms;Perugorria;Nat Rev Gastroenterol Hepatol,2014

2. Polycystic liver disease: advances in understanding and treatment;Masyuk;Annu Rev Pathol,2022

3. Polycystic liver disease: the interplay of genes causative for hepatic and renal cystogenesis;Masyuk;Hepatology,2018

4. Congenital disorders of glycosylation in hepatology: the example of polycystic liver disease;Janssen;J Hepatol,2010

5. It's not all in the cilium, but on the road to it: genetic interaction network in polycystic kidney and liver diseases and how trafficking and quality control matter;Bergmann;J Hepatol,2012

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HDI-STARR-seq: Condition-specific enhancer discovery in mouse liver in vivo;2024-06-26

2. HDI-STARR-seq: Condition-specific enhancer discovery in mouse liver in vivo;2024-06-12

3. Dissecting microenvironment in cystadenomas and hepatic cysts based on single nucleus RNA-sequencing data;Computers in Biology and Medicine;2024-06

4. Multi-omics approach characterizes the role of Bisphenol F in disrupting hepatic lipid metabolism;Environment International;2024-05

5. Histone 3 lysine 9 acetylation-specific reprogramming regulates esophageal squamous cell carcinoma progression and metastasis;Cancer Gene Therapy;2024-01-30